Mabpharm Limited

HKEX:2181.HK

0.295 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 74.06674.066173.345173.34523.14223.14233.56833.56880.28680.28681.55681.556307.178307.178484.846484.846643.345643.345588.72588.721,009.3781,009.378198.195198.195-76.443
Short Term Investments 00000015.04415.0440000000045.6745.67179.16179.160000152.886
Cash and Short Term Investments 74.06674.066173.345173.34523.14223.14248.61248.61280.28680.28681.55681.556307.178307.178484.846484.846689.015689.015767.88767.881,009.3781,009.378198.195198.19576.443
Net Receivables 64.15164.15119.42319.42329.0129.019.5329.5323.853.8500.79311.46811.46800000000000
Inventory 101.703101.703102.037102.037103.237103.237100.797100.79780.35880.35853.21153.21137.66437.66433.42733.42726.74926.74922.22422.22422.42922.42927.55127.5510
Other Current Assets 43.1543.1547.40147.40154.80354.80342.17942.17959.73559.735112.21112.2141.65241.65250.85350.85360.79760.797165.035165.03531.48231.48235.00735.0070
Total Current Assets 283.07283.07342.206342.206210.192210.192201.12201.12224.229224.229247.77247.77397.962397.962569.126569.126776.561776.561955.139955.1391,063.2891,063.289260.753260.75376.443
Non-Current Assets:
Property, Plant & Equipment, Net 657.508657.508690.957686.536689.79685.222713.589704.013705.891669.075642.9561.047549.233476.026559.687512.617508.912492.398389.89332.395246.383213.776154.072122.8330
Goodwill 0000000000000000000000000
Intangible Assets 000000000000000000000038.1100
Goodwill and Intangible Assets 000000000000000000000038.1100
Long Term Investments 0000000000000000000000000
Tax Assets 0000000000000000000000000
Other Non-Current Assets 5.8165.8161.816.2312.9677.5352.81212.3887.88444.79.23291.08531.43104.63734.22481.29431.80348.31751.448108.94397.63130.23720.28789.636-76.443
Total Non-Current Assets 663.324663.324692.767692.767692.757692.757716.401716.401713.775713.775652.132652.132580.663580.663593.911593.911540.715540.715441.338441.338344.013344.013212.469212.469-76.443
Total Assets 946.394946.3941,034.9731,034.973902.949902.949917.521917.521938.004938.004899.902899.902978.625978.6251,163.0371,163.0371,317.2761,317.2761,396.4771,396.4771,407.3021,407.302473.222473.2220
Liabilities & Equity:
Current Liabilities:
Account Payables 12.24612.24610.01210.02616.35716.73616.58616.76628.87476.10512.8660.0856.47253.7494.524.522.9363.0464.4014.50818.45320.5051.7975.8580
Short Term Debt 48.07248.072125.258125.25863.7963.7913.29113.29113.70313.7039.28310.0227.59710.3598.5328.5537.367.8970.572.931103.735104.5654053.0510
Tax Payables 000.65801.33300.93500.88301.20300.43700.59400.37500.51400.24701.75500
Deferred Revenue 056.91900000000000000000000000
Other Current Liabilities 204.994204.994180.263180.907172.384173.338157.589158.344179.561133.213211.658164.897177.324127.722188.981189.554262.714262.449194.919192.895109.443106.808112.89897.5410
Total Current Liabilities 265.312265.312316.191316.191253.864253.864188.401188.401223.021223.021235.004235.004191.83191.83202.627202.627273.385273.385270.334270.334231.878231.878156.45156.450
Non-Current Liabilities:
Long Term Debt 195.56195.56157.315157.315128.682128.682158.046158.046113.295113.29536.40736.40729.90129.90131.81631.81633.14633.14635.12335.12338.20238.20265650
Deferred Revenue Non-Current 00308.0340165.250122.4330110.56026.51014047.10904.35037.30903.47502.200
Deferred Tax Liabilities Non-Current 0000000081.1250-26.510-140-47.1090-4.350-37.3090-3.4750-2.200
Other Non-Current Liabilities 370.331370.331356.41356.41213.78213.78170.13170.130110.56026.51014047.10904.35037.30903.47502.20
Total Non-Current Liabilities 565.891565.891513.725513.725342.462342.462328.176328.176223.855223.85562.91762.91743.90143.90178.92578.92537.49637.49672.43272.43241.67741.67767.267.20
Total Liabilities 831.203831.203829.916829.916596.326596.326516.577516.577446.876446.876297.921297.921235.731235.731281.552281.552310.881310.881342.766342.766273.555273.555223.65223.650
Equity:
Preferred Stock 01,400.50400000000801.3270660.414000396.913000269.5610133.59400
Common Stock 2.8042.8042.8042.8042.8042.8042.8042.8042.8042.8042.8042.8042.8042.8042.8042.8042.8042.8042.8042.8042.8042.8040.0510.0510
Retained Earnings -1,330.243-1,330.243-1,232.674-1,232.674-1,123.317-1,123.317-1,023.318-1,023.318-929.308-929.308-812.499-812.499-665.916-665.916-520.755-520.755-390.311-390.311-336.123-336.123-249.275-249.275-133.594-133.5940
Accumulated Other Comprehensive Income/Loss 42.12642.12634.42334.42326.63226.63220.95420.95417.12817.12811.17211.1725.5025.502-57.71-1.068-6.602-6.602-41.43-13.474-20.286-20.286-26.882-27.31899.813
Other Total Stockholders Equity 1,400.5041,400.5041,400.5041,400.5041,400.5041,400.5041,400.5041,400.5041,400.5041,400.5041,400.5041,400.504740.091,400.5041,400.5041,400.504606.6781,400.5041,400.5041,400.504861.3821,400.504410.433410.43353.476
Total Shareholders Equity 115.191115.191205.057205.057306.623306.623400.944400.944491.128491.128601.981601.981742.894742.894881.485881.4851,006.3951,006.3951,053.7111,053.7111,133.7471,133.747249.572249.572153.289
Total Equity 115.191115.191205.057205.057306.623306.623400.944400.944491.128491.128601.981601.981742.894742.894881.485881.4851,006.3951,006.3951,053.7111,053.7111,133.7471,133.747249.572249.572153.289
Total Liabilities & Shareholders Equity 946.394946.3941,034.9731,034.973902.949902.949917.521917.521938.004938.004899.902899.902978.625978.6251,163.0371,163.0371,317.2761,317.2761,396.4771,396.4771,407.3021,407.302473.222473.222153.289